SteinCares will handle all regulatory filings, registrations and commercialization of Ranibizumab in Latin America, while ...

Diabetes and thyroid disorders often go hand-in-hand, impacting how your body uses energy and controls blood sugar. In India, ...

For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased ...

A new study has found a significant association between the use of GLP-1s such as Ozempic and Wegovy with a higher risk of developing a serious eye condition in patients with diabetes. Here are four t ...

New findings from the CONFIDENCE trial show that combination therapy with finerenone and empagliflozin leads to significantly ...

ZEISS Medical Technology announced today that the CLARUS® 700 from ZEISS has received National Medical Products Administr ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

The global research community has shown accelerating interest in digital health solutions for NCDs, with a dramatic rise in ...

A road safety organisation has warned elderly and older motorists, drivers and road users who live with diabetes, as they ...

A road safety organisation has issued a warning to elderly and older motorists, drivers and road users who are still behind ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

ZEISS Medical Technology announced today that the CLARUS ® 700 from ZEISS has received National Medical Products ...